About the Journal

About the Journal

 

About ASIDE Cardiovascular

Publisher, Ownership, and Academic Oversight

Until February 2026, ASIDE Cardiovascular was published by the American Society for Inclusion, Diversity, and Equity in Healthcare (ASIDE).

Effective from February 2026, ownership and publishing responsibility were transferred to PubPorta Publishing LLC, 16192 Coastal Highway, Lewes, Delaware 19958, USA, which now serves as the publisher and owner of the journal.

Academic oversight and scholarly guidance continue to be provided by the American Society for Inclusion, Diversity, and Equity in Healthcare (ASIDE).

This transition does not affect the journal’s aims and scope, editorial independence, peer-review process, or open-access policies. Previously published content remains accessible under its stated licensing terms.

Vision and Mission

ASIDE Cardiovascular is a peer-reviewed, open-access medical journal dedicated to publishing high-quality research and scholarly content in cardiovascular medicine, vascular medicine, cardiac surgery, preventive cardiology, cardiac imaging, electrophysiology, heart failure, hypertension, and related cardiovascular sciences.

The journal is committed to promoting diversity, equity, inclusion, and accessibility in healthcare by highlighting disparities in cardiovascular outcomes, improving access to evidence-based cardiovascular care, and encouraging scholarship that addresses social and structural factors influencing heart and vascular health.

Its mission is to disseminate rigorous, clinically meaningful, ethically conducted, and educationally valuable work that advances medical knowledge, supports equitable care, and strengthens education, practice, policy, and research across diverse populations.

Aims and Scope

ASIDE Cardiovascular welcomes submissions across the full spectrum of cardiovascular and vascular medicine. The journal considers article types including, but not limited to:

  • Original research articles

  • Systematic reviews and meta-analyses

  • Narrative reviews

  • Clinical trials

  • Case reports and case series

  • Brief reports

  • Editorials and commentaries

  • Letters to the Editor

  • Methodology papers and study protocols where appropriate

  • Quality improvement and implementation research

Topics of interest include, but are not limited to:

  • General cardiology and heart failure

  • Interventional and structural cardiology

  • Electrophysiology and arrhythmia management

  • Cardiac imaging

  • Preventive cardiology, lipid disorders, and hypertension

  • Adult congenital heart disease

  • Cardio-oncology

  • Women’s cardiovascular health

  • Vascular medicine and vascular surgery

  • Aortic disease, peripheral arterial disease, and venous thromboembolic disease

  • Cerebrovascular and stroke-related cardiovascular interfaces

  • Cardiometabolic medicine and population cardiovascular health

  • Implementation science, digital health, cardiac devices, and remote monitoring

  • Social determinants of health, disparities in cardiovascular care, and interventions that improve equitable access

  • Global cardiovascular health and cardiovascular care in low-resource settings

Submissions should provide scientific, clinical, educational, or policy-relevant value and be relevant to clinicians, researchers, trainees, educators, and others working to improve cardiovascular outcomes and equity in care.

Readership

The journal serves cardiologists, vascular specialists, cardiovascular surgeons, internists, electrophysiologists, imaging specialists, nurses, allied health professionals, researchers, educators, policymakers, and public health professionals with an interest in clinically relevant scholarship and equitable healthcare practice.

ASIDE Cardiovascular welcomes contributions and readership from all regions of the world and aims to foster broad international dialogue through accessible, high-quality publication in cardiovascular medicine and vascular science.

Publication Frequency

ASIDE Cardiovascular is published quarterly, with four issues per year. Articles are published online after completion of peer review, editorial processing, and production, and are then assigned to the next available issue.

Language

The journal publishes in English.

Open Access Policy

ASIDE Cardiovascular provides immediate open access to all content. The full text of every article is freely available to read, download, copy, distribute, print, search, or link to without delay, with no embargo and no registration requirement.

Copyright and Licensing

Unless otherwise indicated, all articles are published under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.

This license permits use, sharing, adaptation, distribution, and reproduction in any medium or format, including commercial use, provided appropriate credit is given to the original authors and the source, a link to the license is provided, and changes are indicated.

Authors retain copyright in their work and grant the publisher a non-exclusive right of first publication under the above license. The copyright holder and license are displayed on each article’s HTML page and PDF.

If any material within an article, including images, figures, tables, or data, is not covered by CC BY 4.0, that material will be identified by a credit line stating the applicable rights and restrictions.

Author Fees and Charges

ASIDE Cardiovascular currently charges no submission fees, no article processing charges (APCs), and no publication fees.

If the journal’s fee structure changes in the future, the change will be stated clearly on the journal website. Editorial decisions are independent of any fee or funding consideration.

Revenue Sources and Editorial Independence

The journal is currently supported through its publisher’s operational resources and related non-editorial support arrangements. The journal does not charge APCs at this time.

Editorial decisions are made independently of commercial, financial, institutional, or political influence. Revenue considerations, sponsorships, advertising, reprints, supplements, or any future business arrangements will not affect peer review, editorial assessment, acceptance, rejection, or publication timing.

Advertising Policy

ASIDE Cardiovascular does not currently accept advertising.

If advertising is introduced in the future, advertisements will be clearly distinguished from editorial content and handled independently of editorial decision making. Advertising will not influence peer review or publication decisions.

Direct Marketing Policy

ASIDE Cardiovascular may occasionally send targeted calls for papers or informational messages to researchers whose expertise aligns with the journal’s aims and scope. Any outreach conducted on behalf of the journal is intended to be appropriate, well targeted, truthful, and unobtrusive.

The journal does not guarantee acceptance, indexing, or publication outcomes in any communication and does not request or require payment as a condition of submission. Messages clearly identify the journal and publisher, describe the article types sought where relevant, and direct recipients to the journal’s policies and submission system. Recipients may opt out of future communications where applicable, and such requests will be honored promptly.

Editorial Process

ASIDE Cardiovascular upholds a rigorous editorial and peer-review process managed by an international editorial team committed to scientific quality, ethical publishing, fairness, diversity, and inclusion.

All scholarly submissions undergo an initial editorial assessment, followed, where appropriate, by external peer review. Editorial decisions are based on scholarly merit, methodological rigor, ethical integrity, relevance to the journal’s scope, and the quality of reporting.

Peer Review Policy (Double-Blind)

ASIDE Cardiovascular uses a double-blind peer review model. Reviewer identities are concealed from authors, and author identities are concealed from reviewers as far as reasonably possible within the journal’s workflow.

Manuscripts that pass initial editorial screening are sent for external peer review by independent reviewers with relevant expertise. Reviewers are asked to assess originality, scientific and clinical validity, methodological rigor, ethical conduct, clarity, relevance, and contribution to the field.

Editorial decisions may include acceptance, minor revision, major revision, or rejection. The final decision rests with the journal’s editorial leadership. Revised manuscripts may undergo editorial reassessment and, where needed, further peer review.

Policy on Editorial Involvement, Endogeny, and Conflict Management

If the Editor-in-Chief, an associate editor, a guest editor, or an editorial board member is an author or co-author of a submitted manuscript, that individual must take no part in reviewer selection, editorial discussion, or the final decision on that manuscript.

Such manuscripts will be handled independently by another qualified editor with no relevant conflict of interest.

Editors, reviewers, and authors are expected to disclose any actual, potential, or perceived conflicts of interest that could influence editorial judgment, peer review, interpretation, or reporting of the work. Where a relevant conflict exists, the journal may require disclosure, recusal, alternative handling, or other appropriate management measures.

Publication Ethics and Malpractice Statement

ASIDE Cardiovascular is committed to maintaining the integrity of the scholarly record. The journal follows recognized best practices in publication ethics and aims to act consistently with guidance from organizations such as COPE, ICMJE, OASPA, and Think. Check. Submit.

Editors evaluate submissions on scholarly merit, methodological rigor, relevance, and policy compliance. Reviewers are expected to provide objective, respectful, and evidence-based feedback while preserving confidentiality. Authors must submit original work, cite sources appropriately, disclose conflicts of interest, and comply with applicable ethical and consent requirements.

The journal may issue corrections, retractions, expressions of concern, or other updates when necessary to preserve the integrity of the scholarly record.

Data Sharing and Reproducibility

ASIDE Cardiovascular supports transparency and reproducibility in scholarly publishing. Research articles should include a Data Availability Statement describing whether and how the data, code, materials, or protocols supporting the findings can be accessed.

Underlying data, analysis code, protocols, and other materials necessary to reproduce results should be shared where ethically, legally, and practically possible. When restrictions apply, authors should explain the reason and indicate whether controlled access is available.

Authors are encouraged to deposit datasets in trusted repositories and to archive software or code in public version-controlled repositories where appropriate. Human-participant data must be de-identified and handled in accordance with informed consent, ethics approvals, and applicable law.

Artificial Intelligence and Automated Tools Policy

Authors should disclose the use of generative artificial intelligence or other automated tools when such tools have been used beyond straightforward language correction, formatting, or routine editing. Authors remain fully responsible for the accuracy, originality, integrity, and appropriateness of all submitted content.

Automated tools cannot be listed as authors. Generative AI tools should not be cited as primary sources of scientific or clinical evidence.

To protect confidentiality and research integrity, reviewers and editors should not upload manuscripts or unpublished files to public or commercial generative AI tools for the purpose of generating review reports, editorial assessments, or substantive decision-making text.

Preservation and Archiving Policy

ASIDE Cardiovascular is committed to the long-term preservation and accessibility of its content through the following measures:

  • PKP Preservation Network (PKP PN): application submitted or maintained; upon activation, published content will be preserved through the PKP PN service for OJS journals.

  • Internet Archive: issues and article PDFs are deposited in the Internet Archive for long-term preservation and public access.

  • Institutional and Repository-Based Preservation: authors are encouraged to deposit permitted versions of their work in institutional, funder, subject, and personal repositories.

  • OAI-PMH: metadata and content are available for harvesting via the journal’s OAI-PMH endpoint: https://asidejournals.com/index.php/cardiovascular/oai

If the journal ceases publication, archived content will remain accessible through available preservation systems to the extent permitted by those services.

Repository and Self-Archiving Policy

ASIDE Cardiovascular permits and encourages authors to deposit all versions of their articles in institutional, subject, funder, or personal repositories, and on academic profiles, without embargo:

  • Submitted version (preprint): may be shared at any time

  • Accepted version (Author Accepted Manuscript, AAM): may be shared immediately upon acceptance

  • Published version (Version of Record, VoR): may be shared immediately after publication

Where a version is deposited, authors should include a full citation and a link to the Version of Record or DOI where available. Articles are published under CC BY 4.0. Journal metadata are harvestable via OAI-PMH.

Website Transparency and Accuracy

The journal aims to present accurate, current, and non-misleading information regarding ownership, publisher identity, editorial team, aims and scope, publication schedule, article types, peer review, ethics, fees, archiving, and licensing.

Readers and authors are encouraged to report any factual inconsistency, outdated policy language, or metadata discrepancy to the editorial office.

Contact

For questions about the journal, editorial policies, publication ethics, or submissions, please contact:

ASIDE Cardiovascular
Email: [email protected]

Publisher:
PubPorta Publishing LLC
16192 Coastal Highway
Lewes, Delaware 19958
USA